Riskpilot← Back to searchSign inGet full accessKingos Dyreklinik ApS
APSDissolvedCVR 37662380Randersvej 24BVeterinary activities · NACE 7500Est. 20161 employees
Revenue 2023
DKK 652K
-14% vs 2022
EBITDA margin
9.3%
-72% vs 2022
Equity ratio
47.8%
Financial strength
Net profit 2023
DKK 47K
-78% vs 2022
| Revenue | DKK 652K | -14% |
| EBITDA | DKK 60K | -72% |
| Net profit | DKK 47K | -78% |
| Total assets | DKK 313K | -21% |
| Equity | DKK 149K | -32% |
| Employees | 1 | — |
Legal name
Kingos Dyreklinik ApS
CVR number
37662380
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
2. maj 2016
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af bestyrelsen
Address
Randersvej 24B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18 | 359 | 710 | 860 | 786 | 723 | 762 | 652 |
| Staff expenses | -0 | -236 | -337 | -723 | -867 | -834 | -542 | -592 |
| EBITDA | 18 | 123 | 373 | 137 | -81 | -111 | 219 | 60 |
| Depreciation & amort. | -0 | -0 | -8 | -8 | -8 | -8 | -8 | -0 |
| EBIT | 18 | 123 | 365 | 129 | -89 | -119 | 211 | 60 |
| Net financials | 0 | -1 | -0 | 1 | -2 | -1 | -1 | 3 |
| Profit before tax | 18 | 122 | 364 | 130 | -91 | -120 | 210 | 64 |
| Tax | 4 | 27 | 80 | 29 | -0 | -0 | 0 | 17 |
| Net profit | 14 | 95 | 284 | 101 | -90 | -120 | 210 | 47 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 91 | 240 | 550 | 688 | 586 | 215 | 397 | 313 |
| Equity | 64 | 159 | 338 | 331 | 130 | 11 | 221 | 149 |
| Long-term debt | 0 | 0 | 0 | 33 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 81 | 212 | 323 | 456 | 204 | 177 | 163 |
| Total debt | 27 | 81 | 212 | 356 | 456 | 204 | 177 | 163 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20162023
Equity ratio
47.8%
This company
38.2%
Market median
+25% vs market
20162023
Return on equity
31.2%
This company
18.4%
Market median
+70% vs market
20162023
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20162023
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20162023
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20162023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-05-15 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LK Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kingos Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laura Kingo Tevely | Management | 0 companies |
| Jeppe Henriksen | Board of Directors | 0 companies |
| Mille Kingo Henriksen | Board of Directors | 0 companies |